Queen RX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: a one-time 3-month semaglutide pack with no subscription
Queen RX scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care, and it serves 44 states. It charges from $100 a month, paid up front; its compounded semaglutide, at $133, paid up front, is 33% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Queen RX, run by Mini Labs, LLC, sells compounded semaglutide and tirzepatide as one-time 3-month packs with no subscription. A semaglutide starter pack is $299 up front, about $100 a month; tirzepatide packs run $499 to $599. The price covers the doctor consult and supplies. It sells in 44 states; California, Kansas, Louisiana, Mississippi, New Mexico and West Virginia are excluded.
Is Queen RX legit?
Yes. Queen RX is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Queen RX promo or coupon code?
We know of no promo or coupon code for Queen RX. Its listed price is $100 a month. Coupon sites advertising "Queen RX discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Queen RX compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Queen RX
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Queen RX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Liraglutide
- Starting price
- $100/mo
- What's included
- Medication · Consult
- Availability
- 44 states
- FDA status
- No FDA warning letters found
How Queen RX scores
Six columns, each one computed from something Queen RX has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.0/10$133/month is 33% below the $199 median for compounded semaglutide across the sellers we compare. Every standard-dose price requires paying for several months up front, so Value is capped at 6. A cheaper starter price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.0/10Serves 44 of 50 states.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Queen RX
Last checked October 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: 44 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Queen RX
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Queen RX involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Queen RX shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Queen RX which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $100, tirzepatide $166. That leaves out membership fees, first-month rates and insurance copays.
- Queen RX serves 44 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Queen RX
- Queen RX offers email support
Cancelling Queen RX
Taken from the terms Queen RX publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Full refund if not prescribed
- Early-termination fee
- None
Medications Queen RX lists
Queen RX lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Shown as $299, struck from $399, under a 'Fall into savings' banner. Includes the doctor consult, 3 months of medication, syringes and alcohol pads. No subscription.
Shown as $399, struck from $599, under a 'Fall into savings' banner. Includes the doctor consult, 3 months of medication, syringes and alcohol pads. No subscription.
Shown as $499, struck from $699, under a 'Fall into savings' banner. Includes the doctor consult, 3 months of medication, syringes and alcohol pads. No subscription.
Shown as $599, struck from $999, under a 'Fall into savings' banner. Includes the doctor consult, 3 months of medication, syringes and alcohol pads. No subscription.
Check the price yourself before you pay
Every figure here comes from Queen RX's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $133 a month, 33% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $200 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- Serves 44 states
- We found no FDA warning letters issued to Queen RX
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Queen RX charges
Queen RX charges $100/month.
- Compounded semaglutide (3-month starter): $100/month
- Compounded semaglutide (3-month supply): $133/month
- Compounded tirzepatide (3-month starter): $166/month
- Compounded tirzepatide (3-month supply): $200/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Queen RX's $133 is genuinely below the middle, not just advertised that way. Some of Queen RX's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Oak, at about $100/month, is the closest like-for-like alternative we review.
What Queen RX dispenses
Queen RX prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Queen RX tells you its price before you start the medical questionnaire and the 44 states it serves. We found no FDA warning letters issued to Queen RX. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Queen RX will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Queen RX bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
Queen RX competes on price without an obvious sacrifice elsewhere: $133/month for compounded semaglutide, no FDA warning letters, and wide state coverage.
The Bottom Line
Queen RX scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care, and it serves 44 states. It charges from $100 a month, paid up front; its compounded semaglutide, at $133, paid up front, is 33% below the $199 median among the sellers we compare.
Before you pay Queen RX
Starting at $100 a month. Check today's price, then start the intake.
Where Queen RX is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Queen RX sets more sellers in the same category beside Queen RX on price, states and what the price includes.
Frequently Asked Questions
How to check Queen RX yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
Every seller that ships to your state, side by side: Arkansas, Colorado, Georgia, North Carolina, Oklahoma, Pennsylvania, Texas, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Queen RX review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Queen RX's current pricing
Plans start at $100 a month. Whether you qualify is a clinician's decision, made after your intake.